Akebia Therapeutics to Present at H.C. Wainwright Bioconnect Conference

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA), a biopharmaceutical company focused on improving the lives of those affected by kidney disease, will have its Chief Financial Officer, David Spellman, participate in a virtual fireside chat at the H.C. Wainwright Bioconnect Conference from January 10-13, 2022. An audio replay of the conversation will be available on the Investors section of Akebia's website for 90 days post-conference. Founded in 2007 and headquartered in Cambridge, MA, Akebia is dedicated to developing therapeutics for kidney patients.

CAMBRIDGE, Mass., Jan. 10, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that David Spellman, Chief Financial Officer, will participate in a fireside chat at the H.C. Wainwright Bioconnect Conference, which will take place virtually January 10-13, 2022.  

An audio replay of the fireside chat will be available through the Investors section of Akebia's website at https://ir.akebia.com for approximately 90 days following the conference.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
Mcarrasco@akebia.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-hc-wainwright-bioconnect-conference-301456833.html

SOURCE Akebia Therapeutics

FAQ

What event is Akebia Therapeutics attending in January 2022?

Akebia Therapeutics is participating in the H.C. Wainwright Bioconnect Conference from January 10-13, 2022.

Who is representing Akebia Therapeutics at the conference?

David Spellman, the Chief Financial Officer, will represent Akebia Therapeutics at the conference.

Where can I listen to the replay of Akebia's conference chat?

The audio replay of the fireside chat will be available on Akebia's Investors section of their website for approximately 90 days.

What is the purpose of Akebia Therapeutics?

Akebia Therapeutics aims to improve the lives of individuals impacted by kidney disease.

When was Akebia Therapeutics founded?

Akebia Therapeutics was founded in 2007.

What is the stock symbol for Akebia Therapeutics?

The stock symbol for Akebia Therapeutics is AKBA.